CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
Product revenue	$ 1,571.9	$ 1,611.4	$ 1,556.5
Service revenue	231.8	219.3	210.0
Other revenue	5.2	8.7	24.9
Total revenue	1,808.9	1,839.4	1,791.4
Cost of product revenue	896.0	891.7	837.2
Cost of service revenue	149.6	142.5	124.8
Total cost of revenue	1,045.6	1,034.2	962.0
Gross profit	763.3	805.2	829.4
Operating expenses:
Selling, general and administrative	451.0	437.9	440.4
Research and development	174.2	190.5	195.3
Impairment of assets	11.5		23.8
Other charges, net	21.2	28.6	13.9
Total operating expenses	657.9	657.0	673.4
Operating income	105.4	148.2	156.0
Interest and other income (expense), net	(4.1)	(23.6)	(17.7)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	101.3	124.6	138.3
Income tax provision	41.7	42.8	60.1
Consolidated net income	59.6	81.8	78.2
Net income attributable to noncontrolling interest in consolidated subsidiaries	2.9	1.7	0.7
Net income attributable to Bruker Corporation	56.7	80.1	77.5
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.34	$ 0.48	$ 0.47
Diluted (in dollars per share)	$ 0.33	$ 0.48	$ 0.46
Weighted average common shares outstanding:
Basic (in shares)	167.8	166.5	166.0
Diluted (in shares)	169.5	168.5	167.4
Consolidated net income	59.6	81.8	78.2
Foreign currency translation adjustments	(132.0)	27.3	8.8
Changes in hedging instruments			1.1
Pension liability adjustments (net of tax of $6.5 million, $4.6 million and $3.7 million, respectively)	(22.6)	17.3	(15.0)
Other	0.3
Net comprehensive income	(94.7)	126.4	73.1
Less: Comprehensive income attributable to noncontrolling interests	2.8	1.7	0.3
Comprehensive income attributable to Bruker Corporation	$ (97.5)	$ 124.7	$ 72.8